Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Britannia Launches Hair Growth Trial Utilizing CBD Formula

London, United Kingdom and Toronto, Ontario — Britannia Life Sciences Inc. (CSE: BLAB), a global product development platform for cosmetic and wellness products, is pleased to announce the launch of a consumer trial to test the efficacy of CBD oil as an active ingredient in the treatment of hair loss.

With sales of over £2.5 billion in 2020, the global hair loss treatment market is expected to grow at an annual rate of between 4 and 6% through 2027, based on industry estimates.

This hair growth initiative is aligned with Britannia’s strategy of utilizing its resources and expertise to build a high-value intellectual property portfolio while growing the market for CBD by developing a broad range of new applications across a wide range of products.

Britannia has engaged its subsidiary, Advanced Development and Safety Laboratories (“ADSL“), to finalize the formulation of a topical cream which utilizes CBD-rich, broad-spectrum hemp oil distillate with the goal of promoting hair growth and density.

The consumer trial will be managed by ADSL’s existing First Beauty platform, (, and will be conducted under the guidance and supervision of health professionals. In its initial phase, trial participants will test a lone topical cream, providing weekly feedback, over a six-month period.

Anyone interested in participating in the trial should visit and register to be added to our email list. For further information please contact the Britannia team at

About Britannia Life Sciences Inc.

Britannia Life Sciences Inc. is a global platform offering an integrated suite of services to assist companies along their product development journey. Britannia’s services, including product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations are offered to companies ranging from multinationals to start-ups particularly in the cosmetics, food and wellness industries. Britannia has garnered significant expertise in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations. Britannia’s head office is located at 120 Adelaide Street West, Suite 2400, Toronto, Ontario, M5H 1T1.

For inquiries or more information on Britannia’s growing suite of product development, analytical testing, regulatory and compliance solutions across a range of industries, please visit

Britannia Launches Hair Growth Trial Utilizing CBD Formula

Cannin Investment Group: Your CBD Stocks Experts is your trusted resource for top CBD stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best CBD stocks for 2021. 

Use Cannin as your resource for:

Is it too late to invest in CBD stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in CBD stocks is now. 

Are you interested in the best CBD stocks for 2021 like HempFusion, Inc., Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in CBD companies or stock in cannabis companies in 2021? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from CBD stocks? Looking for the best Canadian cannabis stocks? We can help.

Predict price movements of CBD stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +34% Gains in 2022
  • +56% Gains in 2021
  • +30% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best CBD stocks – we’ll show you how at